| 1. Schwartz S, Patel N, Longmire T, Jayaraman P, Jiang X, Lu H, Baker L, Velez J, Ramesh R, Wavreille AS et al.. (2022) Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor.. Immunother Adv, 2 (1): (ltac019). [PMID:36196369] [10.1021/op500134e] |
| 2. Barth S, Naran K. (2022) TIM-3: a tumor-associated antigen beyond checkpoint inhibition?. Immunother Adv, 2 (1): (ltac021). [PMID:36406467] [10.1021/op500134e] |
| 3. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA et al.. (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.. Nature, 415 (6871): (536-41). [PMID:11823861] [10.1021/op500134e] |
| 4. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.. Nat Immunol, 6 (12): (1245-52). [PMID:16286920] [10.1021/op500134e] |
| 5. Sánchez-Fueyo, Alberto A and 12 more authors.. (2003) Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.. Nature immunology, [PMID:14556005] |
| 6. van de Weyer, Philipp S PS and 5 more authors.. (2006) A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9.. Biochemical and biophysical research communications, (15): [PMID:17069754] |
| 7. Anderson, Ana C AC and 13 more authors.. (2007) Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.. Science (New York, N.Y.), (16): [PMID:18006747] |
| 8. Jones, R Brad RB and 26 more authors.. (2008) Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.. The Journal of experimental medicine, (24): [PMID:19001139] |
| 9. Golden-Mason, Lucy L and 9 more authors.. (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.. Journal of virology, [PMID:19587053] |
| 10. DeKruyff, Rosemarie H RH and 11 more authors.. (2010) T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells.. Journal of immunology (Baltimore, Md. : 1950), (15): [PMID:20083673] |
| 11. Gleason, Michelle K MK and 13 more authors.. (2012) Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.. Blood, (29): [PMID:22323453] |
| 12. Ndhlovu, Lishomwa C LC and 9 more authors.. (2012) Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.. Blood, (19): [PMID:22383801] |
| 13. Leitner, Judith and 5 more authors.. (2013) TIM-3 does not act as a receptor for galectin-9.. PLoS pathogens, [PMID:23555261] |
| 14. Clayton, Kiera L KL and 6 more authors.. (2014) T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases.. Journal of immunology (Baltimore, Md. : 1950), (15): [PMID:24337741] |
| 15. Gorman, Jacob V JV and Colgan, John D JD.. (2014) Regulation of T cell responses by the receptor molecule Tim-3.. Immunologic research, [PMID:24825777] |
| 16. Gautron, Anne-Sophie AS, Dominguez-Villar, Margarita M, de Marcken, Marine M and Hafler, David A DA.. (2014) Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.. European journal of immunology, [PMID:24838857] |
| 17. Tomkowicz, Brian B and 11 more authors.. (2015) TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.. PloS one, [PMID:26492563] |
| 18. Gayden, Tenzin T and 43 more authors.. (2018) Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.. Nature genetics, [PMID:30374066] |
| 19. Gayden, Tenzin T and 43 more authors.. (2019) Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.. Nature genetics, [PMID:30429576] |
| 20. Polprasert, Chantana C and 25 more authors.. (2019) Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.. Blood advances, (26): [PMID:30792187] |
ZJ23F0900968